$WULF
TERAWULF INC.

2022 Q1 Form 10-Q Financial Statement

#000155837022008985 Filed on May 16, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $217.0K $3.073M
YoY Change -92.94% -12.12%
Cost Of Revenue $32.00K $2.077M
YoY Change -98.46% -11.39%
Gross Profit $185.0K $996.3K
YoY Change -81.43% -13.61%
Gross Profit Margin 85.25% 32.42%
Selling, General & Admin $5.985M $246.0K
YoY Change 2332.93% -86.19%
% of Gross Profit 3235.14% 24.69%
Research & Development $134.9K
YoY Change -26.51%
% of Gross Profit 13.54%
Depreciation & Amortization $4.000K $160.6K
YoY Change -97.51% -4.21%
% of Gross Profit 2.16% 16.12%
Operating Expenses $9.352M $1.676M
YoY Change 458.0% -14.69%
Operating Profit -$9.167M -$1.676M
YoY Change 446.96% 106.56%
Interest Expense $5.322M $19.84K
YoY Change 26721.89% -7.64%
% of Operating Profit
Other Income/Expense, Net $40.00
YoY Change -99.6%
Pretax Income -$14.49M -$1.676M
YoY Change 764.5% 102.92%
Income Tax $0.00 -$20.35K
% Of Pretax Income
Net Earnings -$18.18M -$1.676M
YoY Change 984.9% 185.52%
Net Earnings / Revenue -8379.26% -54.53%
Basic Earnings Per Share -$0.18 -$0.03
Diluted Earnings Per Share -$0.18 -$0.03
COMMON SHARES
Basic Shares Outstanding 100.1M 58.82M
Diluted Shares Outstanding 100.1M 58.82M

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.585M $4.428M
YoY Change -19.04% 70.32%
Cash & Equivalents $3.585M $6.300M
Short-Term Investments
Other Short-Term Assets $442.0K $210.9K
YoY Change 109.58% -29.7%
Inventory $1.962M
Prepaid Expenses $5.943M $5.000K
Receivables $1.546M
Other Receivables $17.75K
Total Short-Term Assets $25.96M $6.305M
YoY Change 311.7% -16.03%
LONG-TERM ASSETS
Property, Plant & Equipment $121.9M $7.228M
YoY Change 1586.17% -8.13%
Goodwill
YoY Change
Intangibles $243.8K
YoY Change
Long-Term Investments $123.0M
YoY Change
Other Assets $957.0K
YoY Change
Total Long-Term Assets $246.9M $23.70M
YoY Change 941.69% 191.32%
TOTAL ASSETS
Total Short-Term Assets $25.96M $6.305M
Total Long-Term Assets $246.9M $23.70M
Total Assets $272.8M $30.01M
YoY Change 809.31% 91.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.699M $38.00K
YoY Change 25423.68% -95.25%
Accrued Expenses $13.25M $547.7K
YoY Change 2319.8% 36.92%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $2.654M
YoY Change 1871.9%
Total Short-Term Liabilities $52.94M $1.739M
YoY Change 2944.45% 32.09%
LONG-TERM LIABILITIES
Long-Term Debt $97.66M $0.00
YoY Change -100.0%
Other Long-Term Liabilities $969.0K
YoY Change
Total Long-Term Liabilities $97.66M $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $52.94M $1.739M
Total Long-Term Liabilities $97.66M $0.00
Total Liabilities $151.8M $1.739M
YoY Change 8630.88% -56.2%
SHAREHOLDERS EQUITY
Retained Earnings -$113.9M -$1.676M
YoY Change 6696.6% -119.15%
Common Stock $101.0K $2.838M
YoY Change -96.44% -2.93%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $121.0M $0.00
YoY Change
Total Liabilities & Shareholders Equity $272.8M $30.01M
YoY Change 809.31% 91.8%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income -$18.18M -$1.676M
YoY Change 984.9% 185.52%
Depreciation, Depletion And Amortization $4.000K $160.6K
YoY Change -97.51% -4.21%
Cash From Operating Activities -$21.50M $771.4K
YoY Change -2887.3% -280.53%
INVESTING ACTIVITIES
Capital Expenditures $21.49M $23.70M
YoY Change -9.33% 17439.32%
Acquisitions
YoY Change
Other Investing Activities -$19.07M $0.00
YoY Change -100.0%
Cash From Investing Activities -$40.56M -$23.70M
YoY Change 71.14% -2245.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $6.800M $30.00M
YoY Change -77.33%
Debt Paid & Issued, Net $36.83K
YoY Change 3.21%
Cash From Financing Activities 19.20M 30.00M
YoY Change -36.0% -84176.0%
NET CHANGE
Cash From Operating Activities -21.50M 771.4K
Cash From Investing Activities -40.56M -23.70M
Cash From Financing Activities 19.20M 30.00M
Net Change In Cash -42.87M 6.300M
YoY Change -780.46% 881.63%
FREE CASH FLOW
Cash From Operating Activities -$21.50M $771.4K
Capital Expenditures $21.49M $23.70M
Free Cash Flow -$42.99M -$22.93M
YoY Change 87.49% 3976.92%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
100121370
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58819431
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001083301
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
9566
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
99976253
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
100790239
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-113900000
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-41163
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
TERAWULF INC.
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-1909475
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
9 Federal Street
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
21601
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Easton
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
CY2022Q1 dei City Area Code
CityAreaCode
410
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
770-9500
CY2022Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
CY2022Q1 dei Trading Symbol
TradingSymbol
WULF
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
104639286
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3585000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
43448000
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
3007000
CY2022Q1 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
212000
CY2022Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5943000
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1494000
CY2021Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
647000
CY2022Q1 us-gaap Other Assets Current
OtherAssetsCurrent
442000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
108000
CY2022Q1 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
15775000
CY2021Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
19348000
CY2022Q1 us-gaap Assets Current
AssetsCurrent
25958000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
68052000
CY2022Q1 us-gaap Equity Method Investments
EquityMethodInvestments
123046000
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
104280000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
121873000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
91446000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1004000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1024000
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
957000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
109000
CY2022Q1 us-gaap Assets
Assets
272838000
CY2021Q4 us-gaap Assets
Assets
264911000
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
9699000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
11791000
CY2022Q1 wulf Current Accrued Construction Liabilities
CurrentAccruedConstructionLiabilities
4527000
CY2021Q4 wulf Current Accrued Construction Liabilities
CurrentAccruedConstructionLiabilities
3892000
CY2022Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
8636000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3771000
CY2022Q1 wulf Deferredcompensationsharebasedarrangementliabilityduetorelatedparty
Deferredcompensationsharebasedarrangementliabilityduetorelatedparty
12500000
CY2021Q4 wulf Deferredcompensationsharebasedarrangementliabilityduetorelatedparty
Deferredcompensationsharebasedarrangementliabilityduetorelatedparty
12500000
CY2022Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1306000
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
60000
CY2022Q1 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
10594000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
12000000
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
90000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
88000
CY2022Q1 us-gaap Notes Payable Current
NotesPayableCurrent
3147000
CY2022Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
2444000
CY2021Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
1755000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
52943000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
45857000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
969000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
992000
CY2022Q1 wulf Deferred Tax Liabilities Net
DeferredTaxLiabilitiesNet
256000
CY2021Q4 wulf Deferred Tax Liabilities Net
DeferredTaxLiabilitiesNet
256000
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
97662000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
94627000
CY2022Q1 us-gaap Liabilities
Liabilities
151830000
CY2021Q4 us-gaap Liabilities
Liabilities
141732000
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
9566
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
9273000
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
100790239
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
99976253
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
101000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
100000
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
225545000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
218762000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-113911000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-95683000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
121008000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
123179000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
272838000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
264911000
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
217000
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
32000
CY2022Q1 us-gaap Gross Profit
GrossProfit
185000
CY2022Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
480000
CY2022Q1 wulf Operating Expenses Related Party
OperatingExpensesRelatedParty
62000
CY2021Q1 wulf Operating Expenses Related Party
OperatingExpensesRelatedParty
853000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5985000
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
246000
CY2022Q1 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
2816000
CY2021Q1 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
577000
CY2022Q1 us-gaap Depreciation
Depreciation
4000
CY2022Q1 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
5000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
9352000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
1676000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-9167000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1676000
CY2022Q1 us-gaap Interest Expense
InterestExpense
5322000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-14489000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1676000
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-788000
CY2022Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-15277000
CY2021Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-1676000
CY2022Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-2906000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-18183000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1676000
CY2022Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
45000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-18228000
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1676000
CY2022Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.15
CY2021Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.03
CY2022Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-0.03
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
100121370
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58819431
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
123179000
CY2022Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
9273000
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6784000
CY2022Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
45000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-18183000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
121008000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
0
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
29942000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1676000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
28266000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-18183000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-1676000
CY2022Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2458000
CY2022Q1 us-gaap Depreciation
Depreciation
4000
CY2022Q1 us-gaap Increase Decrease In Intangible Assets Current
IncreaseDecreaseInIntangibleAssetsCurrent
217000
CY2022Q1 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
5000
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-788000
CY2022Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-2906000
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
4449000
CY2022Q1 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-647000
CY2022Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
34000
CY2021Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
5000
CY2022Q1 wulf Increase Decrease In Right Of Use Asset
IncreaseDecreaseInRightOfUseAsset
-20000
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
848000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-6066000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
38000
CY2022Q1 us-gaap Increase Decrease In Construction Payables
IncreaseDecreaseInConstructionPayables
-3870000
CY2022Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
4155000
CY2021Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
203000
CY2022Q1 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
1246000
CY2021Q1 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
1440000
CY2022Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-21000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-21459000
CY2022Q1 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-50000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21509000
CY2022Q1 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
19072000
CY2022Q1 wulf Payments For Deposits On Plant And Equipment Made On Behalf Of Joint Venture Partner
PaymentsForDepositsOnPlantAndEquipmentMadeOnBehalfOfJointVenturePartner
11402000
CY2022Q1 wulf Reimbursement Of Payments For Deposits On Plant And Equipment Made On Behalf Of Joint Venture Partner
ReimbursementOfPaymentsForDepositsOnPlantAndEquipmentMadeOnBehalfOfJointVenturePartner
11402000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
21488000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
23700000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-40560000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-23700000
CY2022Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
4706000
CY2022Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1559000
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6787000
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
30000000
CY2022Q1 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
9266000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
19200000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
30000000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-42869000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6300000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46455000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3586000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6300000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
1427000
CY2022Q1 wulf Revenue Sources Number
RevenueSourcesNumber
2
CY2022Q1 wulf Number Of Facilities
NumberOfFacilities
2
CY2021Q2 wulf Number Of Subsidiaries Created For Operations
NumberOfSubsidiariesCreatedForOperations
3
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-18200000
CY2022Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
2500000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21500000
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3600000
CY2022Q1 wulf Working Capital
WorkingCapital
27000000.0
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
121000000.0
CY2022Q1 wulf Net Invested
NetInvested
19100000
CY2022Q1 wulf Offering Price
OfferingPrice
200000000.0
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6800000
CY2022Q1 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
9300000
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates in the Financial Statements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates are used for (but are not limited to) such items as the fair values of assets acquired and liabilities assumed in business combinations, the fair value of contingent consideration issued in a business combination, the establishment of useful lives for property, plant and equipment and intangible assets, the impairment of goodwill and held for sale assets, the fair value of equity securities issued as a component of a debt offering, the establishment of right-of-use assets and lease liabilities that arise from leasing arrangements, the timing of commencement of capitalization for plant and equipment, recoverability of deferred tax assets and the recording of various accruals. These estimates are made after considering past and current events and assumptions about future events. Actual results could differ from those estimates.</p>
CY2022Q1 wulf Common Stock Issuance Costs In Accounts Payable
CommonStockIssuanceCostsInAccountsPayable
3000
CY2021Q1 wulf Common Stock Issuance Costs In Accounts Payable
CommonStockIssuanceCostsInAccountsPayable
58000
CY2022Q1 wulf Preferred Stock Issuance Costs In Accounts Payable
PreferredStockIssuanceCostsInAccountsPayable
293000
CY2022Q1 wulf Change In Capital Expenditures Incurred But Not Yet Paid
ChangeInCapitalExpendituresIncurredButNotYetPaid
8943000
CY2022Q1 wulf Payments To Acquire Interest In Joint Venture Accrued Liabilities
PaymentsToAcquireInterestInJointVentureAccruedLiabilities
482000
CY2022Q1 wulf Preferred Stock Dividends In Other Accrued Liabilities
PreferredStockDividendsInOtherAccruedLiabilities
45000
CY2022Q1 wulf Preferred Stock Proceeds Receivable In Other Current Assets
PreferredStockProceedsReceivableInOtherCurrentAssets
300000
CY2022Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2022Q1 us-gaap Cash Uninsured Amount
CashUninsuredAmount
2900000
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3600000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
43400000
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3585000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
43448000
CY2022Q1 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
1000
CY2021Q4 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
3007000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3586000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46455000
CY2022Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022Q1 wulf Deposits On Miners
DepositsOnMiners
82700000
wulf Deposits On Miners
DepositsOnMiners
70600000
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
217000
CY2022Q1 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
5000
CY2022Q1 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
212000
CY2022Q1 us-gaap Dilutive Securities
DilutiveSecurities
0
CY2021 us-gaap Dilutive Securities
DilutiveSecurities
0
CY2022Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
12145000
CY2022Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
1406000
CY2022Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
1753000
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
3304000
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
48474000
CY2022Q1 wulf Weighted Average Attrition Rate Percent
WeightedAverageAttritionRatePercent
0.08
CY2022Q1 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
113000000.0
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
121877000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
91446000
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
121873000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
91446000
CY2022Q1 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
760000
CY2021Q1 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
0
CY2022Q1 us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
4000
CY2021Q1 us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
0
CY2021Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P5Y
CY2021Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2021Q2 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.06
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
50000
CY2022Q1 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P9Y1M6D
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
113000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
150000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
150000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
150000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
150000
CY2022Q1 wulf Lessee Operating Lease Liability To Be Paid Year Five And After Year Five
LesseeOperatingLeaseLiabilityToBePaidYearFiveAndAfterYearFive
662000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1375000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1375000
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
316000
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1059000
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
90000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
969000
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2021Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2022Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021Q4 wulf Number Of Stockholders In Transactions
NumberOfStockholdersInTransactions
3
CY2021Q4 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
25000000.0
CY2021Q4 us-gaap Related Party Transaction Rate
RelatedPartyTransactionRate
0.08
CY2022Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
123500000
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
123500000
CY2022Q1 wulf Debt Issuance Costs And Discount Net
DebtIssuanceCostsAndDiscountNet
25838000
CY2021Q4 wulf Debt Issuance Costs And Discount Net
DebtIssuanceCostsAndDiscountNet
28873000
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
97662000
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
94627000
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
97662000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
94627000
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
46313000
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
77187000
CY2022Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
123500000
CY2021Q2 wulf Purchase Agreement Number
PurchaseAgreementNumber
30000
wulf Purchase Agreement Amount Funded For Joint Venture Net
PurchaseAgreementAmountFundedForJointVentureNet
47700000
CY2022Q1 wulf Joint Venture Payment Of Share In Purchase Agreement To Supplier
JointVenturePaymentOfShareInPurchaseAgreementToSupplier
19072000
CY2022Q1 wulf Payments For Deposits On Plant And Equipment Made On Behalf Of Joint Venture Partner
PaymentsForDepositsOnPlantAndEquipmentMadeOnBehalfOfJointVenturePartner
11402000
CY2022Q1 wulf Reimbursement Of Payments For Deposits On Plant And Equipment Made On Behalf Of Joint Venture Partner
ReimbursementOfPaymentsForDepositsOnPlantAndEquipmentMadeOnBehalfOfJointVenturePartner
11402000
CY2022Q2 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
300000
CY2022Q1 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
0
CY2022Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
45000
CY2022Q1 wulf Shares Authorized
SharesAuthorized
225000000
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q1 wulf Common Stock Number Of Votes
CommonStockNumberOfVotes
1
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
CY2021Q4 wulf Related Party Payment In Balance Sheet
RelatedPartyPaymentInBalanceSheet
12500000
CY2022Q1 wulf Cryptocurrency Load Deployment Threshold For Share Based Compensation
CryptocurrencyLoadDeploymentThresholdForShareBasedCompensation
100
CY2022Q1 wulf Cryptocurrency Load Deployment Threshold For Share Based Compensation
CryptocurrencyLoadDeploymentThresholdForShareBasedCompensation
100

Files In Submission

Name View Source Status
0001558370-22-008985-index-headers.html Edgar Link pending
0001558370-22-008985-index.html Edgar Link pending
0001558370-22-008985.txt Edgar Link pending
0001558370-22-008985-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wulf-20220331.xsd Edgar Link pending
wulf-20220331x10q.htm Edgar Link pending
wulf-20220331x10q_htm.xml Edgar Link completed
wulf-20220331xex10d2.htm Edgar Link pending
wulf-20220331xex10d3.htm Edgar Link pending
wulf-20220331xex10d4.htm Edgar Link pending
wulf-20220331xex10d5.htm Edgar Link pending
wulf-20220331xex10d6.htm Edgar Link pending
wulf-20220331xex31d1.htm Edgar Link pending
wulf-20220331xex31d2.htm Edgar Link pending
wulf-20220331xex32d1.htm Edgar Link pending
wulf-20220331xex32d2.htm Edgar Link pending
wulf-20220331_cal.xml Edgar Link unprocessable
wulf-20220331_def.xml Edgar Link unprocessable
wulf-20220331_lab.xml Edgar Link unprocessable
wulf-20220331_pre.xml Edgar Link unprocessable